Primary Care and Aesthetic

UltraMIST® in the Aesthetic Market

The utilization of UltraMIST® technology has made significant inroads into the aesthetic market, offering a non-invasive and highly effective solution for skin rejuvenation and the treatment of various skin conditions. Its remarkable capabilities lie in promoting healing and stimulating collagen production, thus enhancing skin texture, tone, and overall appearance. By gently and painlessly delivering low-frequency ultrasound therapy, UltraMIST® contributes to a range of aesthetic benefits, from reducing the appearance of fine lines and wrinkles to improving skin elasticity and firmness. With clinical data supporting its effectiveness, this technology has become a sought-after option in the aesthetic industry, providing individuals with a safe, comfortable, and non-surgical approach to achieving radiant, youthful skin.

Clinical Benefits of UltraMIST® Therapy

In the clinical realm, UltraMIST® therapy has proven to be a valuable tool in treating various chronic and acute wounds. This non-contact, painless approach accelerates the healing process, minimizing the risk of infection and scarring while promoting tissue regeneration. Additionally, UltraMIST® aids in managing inflammation and controlling bacteria, contributing to better wound care outcomes. Clinical studies consistently demonstrate the therapy's positive impact on wound closure rates and patients' overall well-being, making it an essential addition to modern wound management practices. Its ease of use, patient comfort, and substantial clinical benefits have solidified UltraMIST® as an indispensable component of advanced wound care strategies, ultimately improving the quality of life for individuals dealing with challenging skin conditions and wounds.

Evidence-Based

Administered by trained healthcare personnel to thousands of patients for more than a decade and supported by a vast array of clinical evidence, the UltraMIST® System’s acoustic wave therapy promotes healing by controlling inflammation and reducing bacteria in the wound bed while increasing angiogenesis. Further, promoting healing increases perfusion through vasodilation, ultimately increasing oxygen and nutrients in the tissue.

Indications include, but are not limited to, diabetic foot ulcers, venous leg ulcers, pressure ulcers, and surgical, burn, and deep tissue injuries.

By activating the body’s normal regeneration process, the UltraMIST® System offers significant wound healing advantages. First, it reduces barriers to healing by reducing bacterial overgrowth, disrupting bacterial biofilms, and controlling inflammation. At the same time, UltraMIST® System therapy promotes healing through vasodilation and by accelerating angiogenesis. A meta-analysis of clinical evidence in cases including diabetic foot, ischemic, neuropathic, venous, multifactorial, pressure, surgical, and traumatic ulcers shows that wound closure increased from 24% with standard care to 42% with UltraMIST® use over a 12-week interval.

To accelerate wound healing even more, in between the UltraMIST® System treatments, other standard or advanced wound therapies may be incorporated into the treatment plan — at the discretion of the wound care professional. The result? Faster relief and better quality of life for your patients with less time and resources on costly treatments that don’t work. These savings make the UltraMIST® System a financially viable solution for the patient, the provider, and the healthcare system.

UltraMIST® achieved an 85% Area Reduction in 7 weeks across a wide range of chronic and acute wounds